4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-043707
Director sold 550 shares at an average $55.15 ($30,333)
From the SEC's structured data for this filing
Trades in this filing
McLoughlin Margaret · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-28 | Sale : show line 1 in the form | −200 | $55.01 | $11,002 | 350 | D |
| 2021-06-28 | Sale : show line 2 in the form | −250 | $55.03 | $13,758 | 100 | D |
| 2021-06-28 | Sale : show line 3 in the form | −100 | $55.73 | $5,573 | 0 | D |
| Open-market sales · 550 sh · avg $55.15 · $30,333 | ||||||
Loading xslF345X03/doc4.xml…